002524.SZ SHZ
Guangzheng Eye Hospital Group Co.,Ltd.
1W: +1.0%
1M: +1.0%
3M: +15.4%
YTD: -15.5%
1Y: -13.2%
3Y: -33.1%
5Y: -69.9%
¥4.13 ($0.62)
-0.07 (-1.67%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$1.3B
-18.8% ▼
5Y CAGR: -6.7%
Total Liabilities
$1.1B
-9.7% ▼
5Y CAGR: +9.7%
Shareholders Equity
$113M
-60.2% ▼
5Y CAGR: -33.8%
Cash & Investments
$68M
-25.7% ▼
5Y CAGR: -22.7%
Total Debt
$712M
-18.8% ▼
5Y CAGR: +21.3%
Net Debt
$644M
-18.0% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $151M | $58M | $65M | $91M | $68M |
| Short-Term Investments | $0 | $31M | $0 | $0 | $0 |
| Cash & ST Investments | $151M | $89M | $65M | $91M | $68M |
| Net Receivables | $127M | $179M | $135M | $181M | $147M |
| Inventory | $71M | $0 | $57M | $30M | $26M |
| Other Current Assets | $52M | $72M | $3M | $6M | $3M |
| Total Current Assets | $400M | $341M | $269M | $316M | $261M |
| Property, Plant & Equip. | $314M | $744M | $688M | $620M | $541M |
| Goodwill & Intangibles | $616M | $573M | $416M | $417M | $271M |
| Long-Term Investments | $72M | $7M | $94M | $19M | $0 |
| Other Non-Current Assets | $41M | $124M | $50M | $127M | $143M |
| Total Non-Current Assets | $1.1B | $1.5B | $1.3B | $1.2B | $997M |
| Total Assets | $1.5B | $1.8B | $1.6B | $1.5B | $1.3B |
| — Liabilities — | |||||
| Accounts Payable | $256M | $270M | $158M | $143M | $187M |
| Short-Term Debt | $200M | $172M | $230M | $264M | $273M |
| Deferred Revenue | $427M | $418M | $70M | $0 | $0 |
| Other Current Liabilities | $71M | $492M | $324M | $256M | $122M |
| Total Current Liabilities | $887M | $980M | $814M | $756M | $677M |
| Long-Term Debt | $260M | $0 | $550K | $77M | $65M |
| Other Non-Current Liab. | -$485M | $0 | $19M | $13M | $24M |
| Total Non-Current Liabilities | $266M | $507M | $469M | $508M | $463M |
| Total Liabilities | $1.2B | $1.5B | $1.3B | $1.3B | $1.1B |
| — Equity — | |||||
| Common Stock | $517M | $516M | $515M | $518M | $518M |
| Retained Earnings | -$248M | -$214M | -$308M | -$277M | -$474M |
| Accumulated OCI | $42M | $17M | $47M | $12M | $11M |
| Total Stockholders Equity | $325M | $341M | $273M | $283M | $113M |
| Total Liabilities & Equity | $1.5B | $1.8B | $1.6B | $1.5B | $1.3B |
| — Key Metrics — | |||||
| Total Debt | $460M | $795M | $810M | $877M | $712M |
| Net Debt | $309M | $736M | $744M | $786M | $644M |
| Total Investments | $72M | $38M | $94M | $19M | $0 |